Milza 25 Capsule
By Milza
Rx
10 Capsule in a Strip

Composition
Milnacipran(25mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
July, 2026

liver
When it comes to your liver health and Milza 25 Capsule, there are essential aspects to consider. Based on the available data, using Milza 25 Capsule seems safe for individuals with liver disease. There is a suggestion that adjusting the dosage of this capsule may not be necessary for such patients. However, it is crucial to consult your doctor before starting or continuing the use of this medication. If you have severe liver disease, extra caution is recommended. Always seek guidance from your healthcare provider to ensure the safe and effective use of Milza 25 Capsule.

kidney
Milza 25 Capsule requires caution in patients with kidney disease. Dosage adjustment may be necessary. Consult your doctor.

alcohol
Caution is advised when consuming alcohol with Milza 25 Capsule. Consult your doctor before combining them due to potential risks.

driving
Milza 25 Capsule may impair your thinking or reactions, affecting your ability to drive. Be cautious as side effects could impact driving capability.

pregnancy
Milza 25 Capsule may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor to assess benefits and risks before use.

breastfeeding
Milza 25 Capsule is likely unsafe during breastfeeding, as it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Phenylacetamide Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Serotonin-norepinephrine reuptake inhibitors (SNRIs) |
₹57
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024